Oliveira, R.; Sampaio, Marcelo Ferraz; Armaganijan, Dikran; Bernick, Márcia Martins Silveira; Dórea, Egidio Lima; Hirata, Mario Hiroyuki 
; Hirata, Rosario Dominguez Crespo
Fonte: Atherosclerosis Supplements. Nome do evento: Brazilian Congress of Atherosclerosis. Unidades: HU, FCF
Assuntos: LEPTINA, OBESIDADE, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, R. et al. Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. Amsterdam: Hospital Universitário, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2009APA
Oliveira, R., Sampaio, M. F., Armaganijan, D., Bernick, M. M. S., Dórea, E. L., Hirata, M. H., & Hirata, R. D. C. (2009). Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. Amsterdam: Hospital Universitário, Universidade de São Paulo.NLM
Oliveira R, Sampaio MF, Armaganijan D, Bernick MMS, Dórea EL, Hirata MH, Hirata RDC. Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. 2009 ; 10( 3): 15 res. D010.[citado 2024 nov. 01 ]Vancouver
Oliveira R, Sampaio MF, Armaganijan D, Bernick MMS, Dórea EL, Hirata MH, Hirata RDC. Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes. Atherosclerosis Supplements. 2009 ; 10( 3): 15 res. D010.[citado 2024 nov. 01 ]
